Investments

  • 4

    core sectors

  • 140,000+

    employees across portfolio

  • 150+

    countries with PAI portfolio presence

  • 5

    years average holding period

  • La Compagnie des Desserts

    LCDD is a leading premium frozen desserts supplier for the food service market

    Food & Consumer

  • Theramex

    Theramex is a leading global specialty pharmaceuticals company focused on women’s health

    Healthcare
    • Investment date August 2022
    • Fund PAI Europe VII
    • Headquarters United Kingdom
    • www.theramex.com

  • HKA

    HKA is a leading global consultancy in risk mitigation, dispute resolution, expert witness and litigation support services

    Business Services
    • Investment date August 2022
    • Fund PAI Europe VII
    • Headquarters United Kingdom
    • www.hka.com

  • Uvesco

    A leading regional player in the Spanish food retail sector with a differentiated model based on a high-quality product offering.

    Food & Consumer
    • Investment date April 2022
    • Fund PAI Mid-Market Fund
    • Headquarters Spain
    • www.uvesco.es

  • Veonet

    Veonet is a leading pan-European ophthalmology clinics platform.

    Healthcare

  • Tropicana Brands Group

    Global portfolio of juice brands including Tropicana, Naked, KeVita, Izze, Dole, Copella, and Punica.

    Food & Consumer
    • Investment date February 2022
    • Fund PAI Europe VII
    • Headquarters United States
    • www.tropicana.com

  • Scrigno

    A leading fully integrated opening solutions player in Europe.

    General Industrials
    • Investment date November 2021
    • Fund PAI Mid-Market Fund
    • Headquarters Italy
    • www.scrigno.net

  • Pasubio

    Pasubio is a leading specialised provider of premium leather for the automotive industry.

    General Industrials

  • European Camping Group

    ECG is the European leader in outdoor accommodation.

    Food & Consumer

  • SGD Pharma

    SGD Pharma is a leading global manufacturer of primary glass packaging for the pharmaceutical industry.

    General Industrials
    • Investment date September 2021
    • Fund PAI Europe VII
    • Value at acquisition €825m
    • Headquarters France
    • www.sgd-pharma.com
More investments
Back to top